Your session is about to expire
← Back to Search
High Intensity Interval Exercise for Type 1 Diabetes (HI1T Trial)
N/A
Waitlist Available
Led By Abbie Smith-Ryan, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 48 hours post exercise
Awards & highlights
HI1T Trial Summary
This study is evaluating whether high intensity interval training may have positive impacts for individuals with type 1 diabetes.
Eligible Conditions
- Type 1 Diabetes
HI1T Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 48 hours post exercise
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 48 hours post exercise
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Carbohydrate Metabolism
Change in Fat Metabolism
Secondary outcome measures
Change in Continuous Glucose (Area Under the Curve)
HI1T Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Moderate Intensity Continous Training, then High Intensity TrainingExperimental Treatment2 Interventions
Participants randomly assigned to this arm will first receive moderate intensity continuous training followed by high intensity interval training.
Group II: High intensity interval training, then Moderate Intensity Continuous TrainingExperimental Treatment2 Interventions
Participants randomly assigned to this arm will first receive high intensity interval training followed by moderate intensity continuous training.
Group III: Control: No exerciseActive Control1 Intervention
Participants will complete the same pre- post measurements, with no exercise in between.
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,190,968 Total Patients Enrolled
North Carolina Diabetes Research CenterUNKNOWN
1 Previous Clinical Trials
12 Total Patients Enrolled
Abbie Smith-Ryan, PhDPrincipal InvestigatorUniversity of North Carolina
11 Previous Clinical Trials
475 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger